Panacea Biotec has received a Letter of Award (LoA) from UNICEF for supply of 115 million doses of its bivalent oral polio vaccine (bOPV) worth around $14.95 million (around Rs 127 crore) in CY2025.
The supply of bOPV to UNICEF is for its requirements in countries in Africa / Asia region as per the orders as may be received from time to time.
Panacea Biotec is a leading research based Biotechnology Company with established research, manufacturing and marketing capabilities.